Table 10Quality of life values applied in the model

Health stateUtility scoreSource
Second and third line
Treatment stage (year 1)0.7363Unpublished data from Wild et al. 2005 for “disease progression” from ScHARR
Maintenance stage (years 2/3 post - treatment)0.8050Unpublished data from Wild et al. 2005 for “progression free” patients from ScHARR
>3 years post-treatment0.8800Unpublished data from Wild et al. 2005 for “disease free” patients from ScHARR
Fourth and fifth line
Treatment stage (year 1)0.5300 Prica et al. 2015
>1 year post-treatment0.6180Unpublished data from Wild et al. 2005
Palliation0.3800 Prica et al. 2015

From: 4, Management

Cover of Non-Hodgkin's Lymphoma: Diagnosis and Management
Non-Hodgkin's Lymphoma: Diagnosis and Management.
NICE Guideline, No. 52.
National Guideline Alliance (UK).
Copyright © National Institute for Health and Care Excellence 2016.

All rights reserved. NICE copyright material can be downloaded for private research and study, and may be reproduced for educational and not-for-profit purposes. No reproduction by or for commercial organisations, or for commercial purposes, is allowed without the written permission of NICE.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.